KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Semtech (SMTC) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Semtech (SMTC) over the last 17 years, with Q4 2025 value amounting to $164.7 million.

  • Semtech's Cash & Equivalents rose 2063.38% to $164.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $164.7 million, marking a year-over-year increase of 2063.38%. This contributed to the annual value of $151.7 million for FY2025, which is 1800.99% up from last year.
  • As of Q4 2025, Semtech's Cash & Equivalents stood at $164.7 million, which was up 2063.38% from $168.6 million recorded in Q3 2025.
  • In the past 5 years, Semtech's Cash & Equivalents registered a high of $617.8 million during Q4 2022, and its lowest value of $115.9 million during Q3 2024.
  • Over the past 5 years, Semtech's median Cash & Equivalents value was $166.6 million (recorded in 2025), while the average stood at $221.1 million.
  • Per our database at Business Quant, Semtech's Cash & Equivalents skyrocketed by 12335.62% in 2022 and then crashed by 7995.79% in 2023.
  • Quarter analysis of 5 years shows Semtech's Cash & Equivalents stood at $276.6 million in 2021, then soared by 123.36% to $617.8 million in 2022, then tumbled by 79.96% to $123.8 million in 2023, then rose by 10.24% to $136.5 million in 2024, then rose by 20.63% to $164.7 million in 2025.
  • Its Cash & Equivalents stands at $164.7 million for Q4 2025, versus $168.6 million for Q3 2025 and $156.5 million for Q2 2025.